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Introduction
Community pharmacies have emerged in recent years as strategically important settings with great potential for delivering public health services. One advantage of community pharmacies compared to other healthcare providers is the reach into the population: an estimated 90 per cent of the population make at least one visit per year, 1 suggesting they have the potential to not only target patients with long-term conditions, but also those who do not interact with other healthcare professionals.
Crucially, in England, it has been shown that the distribution of community pharmacies are positively associated with areas of high deprivation -a so-called positive pharmacy care law. 2 Community pharmacies, therefore, are ideally placed in the community to meet healthcare needs of the population and, potentially -through targeting patients that need healthcare the most -reducing certain health inequalities.
This potential has been acknowledged: for example, the White Paper, Pharmacy in England: building on strengths, delivering the future, details how community pharmacists could play a greater role in delivering public health services. 3 One idea was that community pharmacies could act as 'healthy living' centres, providing greater services to the local needs of the population.
In view of this, there is now significant emphasis placed upon community pharmacies delivering patient-focused services, including promoting healthy lifestyles and modification of health-related behaviours, as well as providing medicine-related activities. This change has been supported through the contractual framework for community pharmacy in England, which allows community pharmacists to deliver a range of patient-focused healthcare services. 4 These include: offering treatments for minor ailments, providing support to patients with long-term conditions, offering screening for individuals with high risk of vascular disease, and providing commissioned services based on the needs and health risks of the local population they serve.
Building on the success of the community pharmacy contractual framework and the 'healthy living' centre approach discussed in the White Paper, the Healthy Living Pharmacy (HLP) framework was established, which allows community pharmacies to deliver a portfolio of public health services tailored according to local need. 5, 6 The framework is designed around a tiered commissioning system with three levels, each delivering an increasingly sophisticated suite of services. 7 The overarching themes of the different tiers of service are: health promotion (Level 1), health prevention (Level 2) and health protection (Level 3). Services are thus commissioned according to these activities with smoking, alcohol and weight management key areas of focus. To support the transformation from a community pharmacy to a HLP, there are three 'enablers' that underpin the three levels of service. These are: workforce development and Healthy Living Champions (HLCs) (members of the pharmacy team who have undertaken specific additional training), on site premises fit for the delivery of the service, and engagement with other stakeholders (e.g. GPs, social care and public health professionals).
At present, research suggests that HLPs have the potential of improving the health of some patient groups compared to non-HLPs. 8 However, despite an understanding around barriers associated with implementation, there is little known about the challenges associated with progressing between levels of the framework (notably from Level 1 to 2) or the views of commissioners responsible for commissioning these services. The aim of this study was, therefore, to explore the barriers to the implementation and progression of the HLP framework, from both pharmacy and commissioner perspectives, and to ascertain whether the successes and barriers of the framework perceived by pharmacies are shared with commissioners.
Methods
A structured qualitative interview study was undertaken with the following participants based in the North of England:
• Community pharmacists working in Healthy Living Pharmacies
• Healthy Living Champions working in Healthy Living Pharmacies
• Commissioners who were responsible for commissioning services from
Healthy Living Pharmacies
For the purposes of the study, a community pharmacist was defined as a registrant of the General Pharmaceutical Council, a Health Living Champion was defined as a member of the pharmacy team with a Level 2 qualification in Understanding Health Improvement, as accredited by the Royal Society for Public Health (RSPH), while a commissioner was defined as an individual working within the Local Authority with responsibility for commissioning services from HLPs.
Participants from HLPs (pharmacists or HLCs) were purposively sampled, according to the ward-level unemployment data as a proxy for relative deprivation of the community pharmacy 9 and, if they were progressing to the next tier of the framework.
Community pharmacies in areas with unemployment of under 6 per cent were classified as low deprivation, unemployment between 6 and 10 per cent as medium deprivation, and unemployment over 10 per cent as high deprivation. Commissioners
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were sampled according to their specific area of responsibility (e.g. smoking, alcohol or weight management).
Among the 22 HLPs in the study region, interviews were carried out at 11: five in those progressing to Level 2 and six in those remaining at Level 1 (Table 1) . In each HLP, a pharmacist and HLC were interviewed. Interviews were also conducted with four members of a Local Authority responsible for commissioning the HLP framework; specifically, the heads of the smoking cessation, weight management, substance misuse and health checks aspects of the framework. These four individuals were selected as smoking, alcohol use and obesity are the three most significant social determinants of health, and the health checks comprise a major aspect of the framework. Data collection took place between May and August 2014.
A structured-interview approach was adopted, to ensure that each respondent was asked exactly the same questions, keeping to the same wording for each interview.
This consistency minimised error, as even small changes to wording can exert impact on responses. 10 The interview schedule was developed after informal meetings with community pharmacists working in HLPs, and commissioners. The interview questions were then piloted with one commissioner and two community pharmacists and, based on feedback modified for the main set of interviews. The interview questions for community pharmacists and HLCs are outlined in Box 1 and those for commissioners in Box 2. There was also a positive theme that the HLP framework had been beneficial to engagement and accessibility with pharmacy users. Many pharmacies described becoming more proactive in approaching people with health promotion since joining the HLP framework. This was thought to be due to the combination of training, which increased the knowledge and expertise of staff at pharmacies, and the health promotion zone, which roused interest and stimulated questions: 'It has definitely positively affected engagement, pretty much everyone is approached about something' (Pharmacist from HLP 6).
Smoking cessation emerged strongly as the most well-used and successful aspect of the framework. When asked to describe the general successes of the framework, stop smoking was the most common response. This describes a dual benefit in that it is an effective service and it brings business revenue to the pharmacy: 
Barriers to implementing the HLP
However, there were areas of concern amongst pharmacists and HLCs -about low awareness, the time involved in delivery, and financial considerations. These were exemplified by the health checks element -and some of these concerns were shared by commissioners. Many pharmacies described a lack of awareness of HLP as a primary barrier to success. When asked to describe the impact of HLP Level 1 on the local community, many responded that a lack of awareness prevented people from taking full advantage of the services available at HLPs: 'Awareness is low, I don't think many of our customers know we're HLP' (Healthy Living Champion from HLP 4).
They also stated that a significant challenge posed by the HLP framework was the extra time it demanded. When asked to describe the impact on the pharmacy workforce, many pharmacies described an increased workload due to increased administration, keeping up with promotions, performing the health checks and smoking cessation consultations, and losing staff to go on additional training courses:
'I've had to employ more people to cope with the increased workload; we are now
overstaffed in terms of prescription volumes as we're too busy doing HLP'
(Pharmacist from HLP 10).
Some pharmacists described being disappointed that the framework had not been beneficial from a business perspective. In particular, those who described their expectations of the framework to increase the number of customers were dissatisfied.
Financial concerns were commonly stated as the reasoning for declining Level 2:
'There's nothing to be gained by it and in this economic climate we can't afford to lose staff for training' (Pharmacist from HLP 4).
These concerns were most apparent in regard to the health checks -which were seen The interviews with commissioners also highlighted other barriers -on the commissioning side -most notably a lack of cohesion between commissioners and service providers and a poor understanding of the broader framework. The aspirations of commissioners were narrowly focused only on the specific aspect they commissioned e.g. increasing smoking cessation numbers. There was little connection with the different priorities held by pharmacy staff, whose aspirations were to promote health more generally through their pharmacy as well as increase business.
In terms of understanding of the broader framework, it became clear that the commissioners only had knowledge about the specific aspect they were commissioning, and generally had a poor understanding of the wider framework. 
Discussion
Our study identified four main benefits -as perceived by the providers -arising from the HLP framework, indicating that although these benefits are largely intangible, the HLP framework appears to be a valuable one. The commissioners did not replicate these themes, although when it came to identifying barriers toward implementation there was commonality amongst themes. Firstly, improvements to the development and capacity of pharmacy workers were reported, resulting from the training carried out through the HLP framework. Secondly, this study identified that engagement between pharmacy workers and pharmacy users has improved, due to increased knowledge and expertise of staff, and by virtue of the wider range of services available at HLPs. Thirdly, by becoming a HLP, this process had motivated and encouraged pharmacy teams. And finally, providers also perceived the smoking cessation service as a valuable aspect to the HLP framework. This supports previous research that has shown smoking cessation services delivered in a community pharmacy setting can be valuable. These findings align with the trajectory of community pharmacy playing a key role in delivering public health services and supports previous work that showed HLPs have a positive impact on service development and staff training. 5 We also found several barriers to the framework -both in terms of the overall implementation and in progression to Level 2. Indeed, the providers identified a lack of financial reward and the time required to deliver the services associated with the framework as barriers. Similarly, Mackridge and colleagues also identified fluctuations in funding and increased workload as barriers toward delivering an alcohol identification and brief advice (IBA) service in a community pharmacy setting. 12 Our work, although not directly associated with delivery of an IBA service, supports these findings. Another barrier identified in our study was due to the perceived lack of awareness of the HLP framework by the general population. This lack of awareness may not only impact on the number of patient's receiving services, but also on the monetary outcomes the community pharmacy receives for offering the framework. Providers reported this as a reason for not progressing to Level 2 of the framework. If the HLP framework is to improve the health of more people there should be a campaign -possibly through the local and national media -to raise public awareness in the service. Another reported barrier for not progressing to Level 2 of the framework was the health checks. Many community pharmacies -particularly those located in areas of high deprivation -struggled with recruitment, and the timeconsuming nature of delivering them. At present, at Level 1 of the framework, each HLP has to undertake 60 full health checks. This can be challenging depending on the patient demographic using the community pharmacy. Indeed, one pharmacist commented that the majority of the patients using the pharmacy were ineligible for the checks because they already have established heart disease. The commissioners also raised concerns about the health checks: one described feeling 'torn' about the health check service, and that it should be 'separated' from the HLP framework. This finding is timely as the effectiveness of health checks have been recently under debate; a recent review showed there is no evidence to support them. 13 However, despite the lack of robust evidence of effectiveness, health checks are still incorporated into healthcare policy throughout the UK. In many cases, it is possible the emotive rhetoric of individual success stories dominate the views of health check advocates; distinctions must therefore be made between 'good evidence' and 'good stories'.
14 While we believe our results are robust and have important implications for the future commissioning of the HLP framework, we acknowledge that providers and commissioners were interviewed from only one region in the North of England and that this is a small-scale qualitative study. Generalisation of this work to other regions of the UK and more widely should therefore only be made carefully.
Conclusion
The HLP framework was perceived as valuable by providers and appeared to develop the workforce, which in turn, motivated the wider pharmacy team to approach patients about their health. However, there were areas of concern amongst implementation. A key barrier to the framework -perceived by both providers and commissioners -was the implementation of health checks. This should be considered in future commissioning.
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